These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 7771027

  • 1. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA, Ward DM, Lindberg JS, Allen JM, Husserl FE, Marcucci PA, Cole FE, Turnipseed J, Alam J, Kok DJ.
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [Abstract] [Full Text] [Related]

  • 2. Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton.
    Erwin DT, Kok DJ, Alam J, Vaughn J, Coker O, Carriere BT, Lindberg J, Husserl FE, Fuselier H, Cole FE.
    Am J Kidney Dis; 1994 Dec; 24(6):893-900. PubMed ID: 7985666
    [Abstract] [Full Text] [Related]

  • 3. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M, Nakagawa Y, Zipperle L, Hess B.
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [Abstract] [Full Text] [Related]

  • 4. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A, Hochreiter W, Jaeger P, Hess B.
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation.
    Hess B, Zipperle L, Jaeger P.
    Am J Physiol; 1993 Dec; 265(6 Pt 2):F784-91. PubMed ID: 8285211
    [Abstract] [Full Text] [Related]

  • 9. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ, Papapoulos SE, Bijvoet OL.
    Lancet; 1986 May 10; 1(8489):1056-8. PubMed ID: 2871335
    [Abstract] [Full Text] [Related]

  • 10. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W.
    Am J Kidney Dis; 2006 Oct 10; 48(4):546-54. PubMed ID: 16997050
    [Abstract] [Full Text] [Related]

  • 11. Crystal agglomeration is a major element in calcium oxalate urinary stone formation.
    Kok DJ, Papapoulos SE, Bijvoet OL.
    Kidney Int; 1990 Jan 10; 37(1):51-6. PubMed ID: 2299809
    [Abstract] [Full Text] [Related]

  • 12. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 13. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R, Vescini F.
    Arch Ital Urol Androl; 2009 Sep 07; 81(3):182-7. PubMed ID: 19911682
    [Abstract] [Full Text] [Related]

  • 14. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M, Mulinari RA, Nakagawa Y.
    Braz J Med Biol Res; 2002 Oct 07; 35(10):1165-72. PubMed ID: 12424489
    [Abstract] [Full Text] [Related]

  • 15. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
    Hess B.
    Urol Res; 1992 Oct 07; 20(1):83-6. PubMed ID: 1736492
    [Abstract] [Full Text] [Related]

  • 16. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V, Kalaiselvi P, Sumitra K, Srinivasan S, Varalakshmi P.
    Clin Chim Acta; 2005 Oct 07; 360(1-2):141-50. PubMed ID: 15992786
    [Abstract] [Full Text] [Related]

  • 17. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG, Berg C, Fornander AM, Nilsson MA.
    Scanning Microsc; 1993 Mar 07; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [Abstract] [Full Text] [Related]

  • 18. Chronobiology of urinary citrate excretion amongst stone-formers and healthy males from north western India.
    Wangoo D, Thind SK, Gupta GS, Nath R.
    Urol Res; 1991 Mar 07; 19(3):203-6. PubMed ID: 1887530
    [Abstract] [Full Text] [Related]

  • 19. Decreased Tamm-Horsfall protein in lithiasic patients.
    Romero MC, Nocera S, Nesse AB.
    Clin Biochem; 1997 Feb 07; 30(1):63-7. PubMed ID: 9056112
    [Abstract] [Full Text] [Related]

  • 20. Urinary Tamm-Horsfall protein and citrate: a case-control study of inhibitors and promoters of calcium stone formation.
    Pourmand G, Nasseh H, Sarrafnejad A, Mehrsai A, Hamidi Alamdari D, Nourijelyani K, Shekarpour L.
    Urol J; 2005 Feb 07; 2(2):79-85. PubMed ID: 17629875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.